HEMATURIA RESOLUTION WITH THE APRIL-BLOCKING MONOCLONAL ANTIBODY, SIBEPRENLIMAB, IN PATIENTS WITH IgA NEPHROPATHY IN A PHASE 2 RANDOMIZED CONTROLLED TRIAL

https://storage.unitedwebnetwork.com/files/1099/72cf9532c877f4340e22243e35c15d51.pdf
HEMATURIA RESOLUTION WITH THE APRIL-BLOCKING MONOCLONAL ANTIBODY, SIBEPRENLIMAB, IN PATIENTS WITH IgA NEPHROPATHY IN A PHASE 2 RANDOMIZED CONTROLLED TRIAL
Jonathan
Barratt
Richard Lafayette czar@stanford.edu Stanford University Department of Medicine Stanford
Hitoshi Suzuki shitoshi@juntendo.ac.jp Juntendo University Urayasu Hospital Department of Nephrology Chiba
Sreelatha Melamadothil nephcal@gmail.com Government Medical College, Kozhikode Department of Nephrology Kerala
Laura Kooeinga lkooienga@cokidneycare.com Colorado Kidney Care Research Division Denver
Chula Herath chulaherath@gmail.com Sri Jayewardenepura General Hospital Department of Nephrology Unit Nugegoda
Muh Geot Wong muh.wong@health.nsw.gov.au Concord Repatriation General Hospital Renal Research Concord
David Oldach doldach@visterrainc.com Visterra, Inc Nephrology Clinical Development Boston
Asher Schachter aschachter@visterrainc.com Visterra, Inc Nephrology Clinical Development Boston
Mohit Mathur mmathur@visterrainc.com Visterra, Inc Nephrology Clinical Development Boston
Yusuke Suzuki yusuke@juntendo.ac.jp Juntendo University Faculty of Medicine Department of Nephrology Tokyo